APA
Ohl K., Fragoulis A., Klemm P., Baumeister J., Klock W., Verjans E., Böll S., Möllmann J., Lehrke M., Costa I., Denecke B., Schippers A., Roth J., Wagner N., Wruck C. & Tenbrock K. (2018). Nrf2 Is a Central Regulator of Metabolic Reprogramming of Myeloid-Derived Suppressor Cells in Steady State and Sepsis. : Frontiers in immunology.
Chicago
Ohl Kim, Fragoulis Athanassios, Klemm Patricia, Baumeister Julian, Klock Wiebke, Verjans Eva, Böll Svenja, Möllmann Julia, Lehrke Michael, Costa Ivan, Denecke Bernd, Schippers Angela, Roth Johannes, Wagner Norbert, Wruck Christoph and Tenbrock Klaus. 2018. Nrf2 Is a Central Regulator of Metabolic Reprogramming of Myeloid-Derived Suppressor Cells in Steady State and Sepsis. : Frontiers in immunology.
Harvard
Ohl K., Fragoulis A., Klemm P., Baumeister J., Klock W., Verjans E., Böll S., Möllmann J., Lehrke M., Costa I., Denecke B., Schippers A., Roth J., Wagner N., Wruck C. and Tenbrock K. (2018). Nrf2 Is a Central Regulator of Metabolic Reprogramming of Myeloid-Derived Suppressor Cells in Steady State and Sepsis. : Frontiers in immunology.
MLA
Ohl Kim, Fragoulis Athanassios, Klemm Patricia, Baumeister Julian, Klock Wiebke, Verjans Eva, Böll Svenja, Möllmann Julia, Lehrke Michael, Costa Ivan, Denecke Bernd, Schippers Angela, Roth Johannes, Wagner Norbert, Wruck Christoph and Tenbrock Klaus. Nrf2 Is a Central Regulator of Metabolic Reprogramming of Myeloid-Derived Suppressor Cells in Steady State and Sepsis. : Frontiers in immunology. 2018.